🎉 We’re thrilled to announce the launch of EmbraceMini, the world’s smallest actigraphy wearable developed for clinical trials. Part of the Empatica Health Monitoring Platform, EmbraceMini combines power and practicality. It continuously collects actigraphy data, with 200+ sleep and activity digital measures to choose from, all packed into a discreet and lightweight device that is not just a bracelet, but can be worn on various parts of the body. ✅ Trial participants benefit from non-invasive data collection, while ensuring sponsors get the quality data they need. Want to find out more? Read our EmbraceMini blog post: https://lnkd.in/dG2P5kej
Empatica
Biotechnology Research
Boston, Massachusetts 38,031 followers
Medical wearables and AI that empower thousands of patients, clinicians and researchers with real-time human insight.
About us
Empatica is an affective computing company, focused on human data analytics. We develop groundbreaking wearable devices with medical quality sensing. Our technology comprises a set of wristband, software running on smartphone and desktop computing, plus real time syncing with a cloud computing service.
- Website
-
https://www.empatica.com
External link for Empatica
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2011
- Specialties
- Affective Computing, Software Development, Hardware Development, and Wearable Computing
Locations
-
Primary
45 Bromfield St
901
Boston, Massachusetts 02108, US
-
Via Stendhal, 36
Milano, MI 20144, IT
Employees at Empatica
Updates
-
🧠 How early can we detect a migraine before it begins? A study published in Healthcare by researchers at Vilnius Gediminas Technical University and Vilnius University explores the use of physiological signals captured during sleep to anticipate the onset of migraine attacks. Using the Empatica EmbracePlus and E4 wearables, researchers monitored ten individuals with episodic migraine and applied multiple machine learning models to analyze changes in electrodermal activity, skin temperature, and movement patterns. Short analysis windows of just 5 to 10 minutes during nocturnal sleep revealed significant physiological shifts during pre-migraine nights, suggesting that early detection may be possible with the right combination of biosensor data and algorithmic insight. The research adds to a growing body of evidence that continuous, high-resolution physiological monitoring can reveal previously invisible patterns in chronic neurological conditions.
-
-
⌚ We know that seamless data collection is essential for clinical trials. But in order to ensure high compliance and data quality, the right wearable technology is needed. We recently announced EmbraceMini, the world’s smallest actigraphy wearable for clinical trials, helping you balance strong participant compliance with reliable data and cost effectiveness. Download our digital leaflet to see how EmbraceMini can help enhance your upcoming trial → https://lnkd.in/dvPtiykM
-
-
Missed our EmbraceMini webinar? You can now watch it on demand, anytime, anywhere. In this session, we cover: 🔍 Key trends and challenges shaping today’s clinical trials 🎯 A closer look at EmbraceMini’s design, features, and form factor 📊 Data quality and validation highlights 🙋 Site and patient experience walkthrough Whether you're exploring new DHTs or looking for a smarter solution for your next study, this is your chance to get caught up. Watch now: https://lnkd.in/dzePza9M #ClinicalTrials #DigitalHealth #DHT #Actigraphy #ClinicalResearch #Empatica #WearableTech #DecentralizedTrials #HybridTrials
-
-
🚀 Are you seeking a new opportunity? #WeAreHiring in Boston and Milan! If you’re passionate about working for a company that builds technology to improve lives, apply today. We have open positions in a range of different departments. See some of our open applications below ⬇️ Want to find out more? Head to our careers page: https://lnkd.in/dEgzeRm7 #Vacancy #LifeAtEmpatica #ApplyToday
-
📊 Cast your vote in our #ThisOrThat poll. Do you prefer an espresso or an iced coffee? As Empatica has an office in Italy, coffee is a staple here! On average, at Empatica we drink 12,000 cups of coffee each year.
This content isn’t available here
Access this content and more in the LinkedIn app
-
⌚ The world’s smallest actigraphy wearable for clinical research, EmbraceMini, helps you achieve continuous sleep and activity digital biomarker monitoring and raw data collection in #ClinicalTrials. High-frequency actigraphy sensor data is collected continuously from 4 powerful sensors, including: ✔️Ambient light sensor: To sense the amount of ambient light that is present ✔️ 3-axis Accelerometer: Used to measure raw acceleration ✔️ 3-axis Gyroscope: Designed to measure angular velocity and orientation ✔️ 3-axis Magnetometer: Used to determine orientation and position With EmbraceMini, collect all of the sleep and activity data needed for your research non-intrusively. Discover EmbraceMini: https://lnkd.in/dHEbVpuP
-
With EmbracePlus, get all the physiological data you need for your trial while ensuring practicality for participants. Its comfortable and breathable strap, along with its award-winning design, ensure all-day comfort for participants, while providing access to all the raw data needed for your research. #WearableTechnology #DigitalBiomarkers
-
-
⌚ Are you seeking an actigraphy wearable that your trial participants will love? Our newly revealed EmbraceMini is just that. Compact, discreet, and non-invasive, with the power and quality researchers need for sleep and activity data collection in #ClinicalTrials. Sensor data is wirelessly transmitted to the Empatica Health Monitoring Platform, enabling the continuous analysis and extraction of precise digital biomarkers, with over 200 sleep and activity measures to choose from. Discover EmbraceMini: https://lnkd.in/d9chCqaw
-
🚀As we close the first half of 2025, we’re reflecting on our event highlights from the year so far. In H1 we attended 7️⃣ events in 2️⃣ continents and 5️⃣ cities, supporting pharmaceutical companies, CROs, researchers, and those in the epilepsy community. 🗓️ We’re looking forward to meeting lots of you at some of our upcoming 2025 events: ✔️August - 36th International Epilepsy Congress in Lisbon ✔️September - DPHARM in Philadelphia ✔️December - AES in Atlanta